Notify me when Matt Abernethy files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | Chief Financial Officer | $6,744,854 | 04 Mar 2026 | ||
| FATE | FATE THERAPEUTICS INC | Director | 29 May 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|